Table 2.
Mean and standard deviations of actigraphy variables for responders and non-responders, and p levels for analyses of difference scores from baseline to post treatment week 2.
| Responders |
Non responders |
p# |
|||||
| N | Mean | SD | N | Mean | SD | ||
| Baseline rest time (min) | 6 | 551.41 | 71.14 | 12 | 540.98 | 49.77 | |
| Post 2 rest time | 4 | 566.31 | 46.04 | 9 | 494.20 | 71.58 | >.10 |
| Baseline sleep efficiency (%) | 6 | 68.05 | 27.65 | 11 | 77.91 | 11.19 | |
| Post treatment 2 sleep efficiency (%) | 4 | 78.42 | 9.26 | 9 | 81.70 | 9.62 | .07 |
| Baseline WASO (min) | 6 | 73.82 | 26.60 | 11 | 76.97 | 60.35 | |
| Post treatment 2 WASO (min) | 4 | 90.94 | 32.91 | 9 | 60.99 | 44.92 | >.10 |
| Baseline TST (min) | 6 | 397.14 | 159.86 | 11 | 427.16 | 63.24 | |
| Post treatment 2 TST (min) | 4 | 441.88 | 21.15 | 9 | 412.73 | 58.96 | .03 |
| Baseline SOL (min) | 6 | 42.07 | 63.57 | 11 | 20.75 | 18.88 | |
| Post treatment 2 SOL (min) | 4 | 17.75 | 19.03 | 9 | 22.55 | 22.83 | .08 |
| Baseline number of wake bouts | 6 | 32.38 | 12.33 | 12 | 25.13 | 11.17 | |
| Post 2 number of wake bouts | 4 | 37.31 | 6.85 | 9 | 24.72 | 9.43 | >.10 |
| Baseline SFI | 6 | 41.56 | 14.38 | 11 | 44.44 | 34.61 | |
| Post treatment 2 SFI | 4 | 40.85 | 10.18 | 9 | 34.66 | 19.12 | >.10 |
WASO=wake after sleep onset; TST=total sleep time; SOL=sleep onset latency; SFI = sleep fragmentation index.
#
Wilcoxeon test p levels, comparing the difference in responders to the difference in non-responders (from baseline to post-treatment week 2 for each group).